Ban, J K <br/><br/>
Denosumab utilization among older adults in Ontario: patient characteristics, persistence with therapy, and return to therapy after an extended gap.  [electronic resource] 

 -  Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA  Sep 2019 
 - 1865-1872 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1433-2965 
<br/><br/><label>Standard No.: </label>10.1007/s00198-019-05051-1  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Aged, 80 and over<br/>Bone Density--drug effects<br/>Bone Density Conservation Agents--administration & dosage<br/>Databases, Factual<br/>Denosumab--administration & dosage<br/>Drug Administration Schedule<br/>Drug Utilization--statistics & numerical data<br/>Female<br/>Follow-Up Studies<br/>Hip Fractures--epidemiology<br/>Humans<br/>Kaplan-Meier Estimate<br/>Male<br/>Ontario--epidemiology<br/>Osteoporosis--drug therapy<br/>Osteoporosis, Postmenopausal--drug therapy<br/>Osteoporotic Fractures--epidemiology<br/>Patient Dropouts--statistics & numerical data<br/>Residence Characteristics--statistics & numerical data<br/>Assessment of Medication Adherence